低HER2的乳腺癌: HER2表达的演变从原发性瘤到远程转移
Mengyuan Cai1,2,3, Ming Li1,2,3, Hong Lv1,2,3
1Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
BMC cancer
|July 13, 2023
概括
在乳腺癌转移中,HER2的表达会发生变化,其速率因转移部位,原发性瘤阶段和活检类型而异. 转移中的这些HER2表达变化没有影响患者的生存结果.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 医学诊断 医学诊断 医学诊断
背景情况:
- 由于新的抗HER2疗法,HER2-低乳腺癌 (BC) 正在引起人们的注意.
- 了解转移中的HER2表达动态对于治疗决策至关重要.
研究的目的:
- 调查 HER2 表达状态在初级 HER2 低乳腺癌及其远程转移.
- 分析影响转移中的HER2状态变化的因素及其预后影响.
主要方法:
- 对98名在2012-2021年期间被诊断为低HER2BC患者 (IHC1+或IHC2+/ISH-) 的回顾性分析.
- 在初级瘤和转移部位中评估HER2表达.
- 基于转移部位,初级瘤T阶段和转移样本类型的HER2异常率的比较.
主要成果:
- 在27.6%的患者中,HER2状态在转移方面有所不同.
- 不一致率因转移部位,初级T阶段和转移样本类型 (活检与外科手术) 不同.
- 根据转移中的HER2状态,没有观察到总体存活率或无病存活率的显著差异.
结论:
- 在HER2-低乳腺癌的转移中,HER2表达可能会发生改变.
- HER2变化的速度受到转移部位,原发性瘤阶段和样本类型的影响.
- 在HER2-低BC转移中改变HER2表达似乎没有预后意义.
相关概念视频
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K


